US Patent Issued to Whitehead Institute for Biomedical Research on Aug. 12 for "Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,055, issued on Aug. 12, was assigned to Whitehead Institute for Biomedical Research (Cambridge, Mass.).

"Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2" was invented by Michael Torrens-Spence (Cambridge, Mass.) and Jing-Ke Weng (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Transgenic host cells, vectors useful for making transgenic host cells, and kits useful for making transgenic host cells are described. Also described are transgenic plants. In some embodiments, transgenic host cells express a 4-hydroxyphenylacetaldehyde synthase (4HPAAS). In some embodiments, t...